NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,135 filers reported holding NOVARTIS A G in Q1 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $255,184 | -6.2% | 2,397 | -14.7% | 0.01% | -8.3% |
Q1 2024 | $271,908 | +121831.8% | 2,811 | +27.2% | 0.01% | +9.1% |
Q4 2023 | $223 | +5.7% | 2,210 | +6.4% | 0.01% | 0.0% |
Q3 2023 | $211 | -99.9% | 2,078 | -7.4% | 0.01% | -42.1% |
Q4 2019 | $212,000 | +5.5% | 2,245 | -3.1% | 0.02% | -5.0% |
Q3 2019 | $201,000 | -21.8% | 2,316 | -21.9% | 0.02% | -79.2% |
Q4 2015 | $257,000 | – | 2,966 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 318,637 | $27,960,000 | 7.08% |
MANAGED ASSET PORTFOLIOS, LLC | 417,183 | $36,608,000 | 5.02% |
SAL Trading, LLC | 233,600 | $20,498,000 | 4.77% |
SCHARF INVESTMENTS, LLC | 1,340,680 | $117,662,000 | 3.49% |
SAL Trading, LLC | 155,783 | $13,670,000 | 3.18% |
First Fiduciary Investment Counsel, Inc. | 169,371 | $14,862,000 | 2.90% |
PRENTISS SMITH & CO INC | 55,026 | $4,829,000 | 2.90% |
GARLAND CAPITAL MANAGEMENT INC | 47,630 | $4,180,000 | 2.77% |
Cullen Capital Management, LLC | 3,295,271 | $289,160,000 | 2.66% |
WILKINS INVESTMENT COUNSEL INC | 133,880 | $11,748,000 | 2.65% |